Drug giant Johnson & Johnson Tuesday reported a slight decline in first-quarter net earnings, while earnings per share increased with higher sales. Adjusted earnings topped analysts' estimates, while sales missed their view. Further, the company raised its earnings and sales outlook for fiscal 2017, including the estimated impact of the Actelion transaction.
from RTT - Earnings http://ift.tt/2puVzC9
via IFTTT
No comments:
Post a Comment